查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1418356

瑞德西韦市场报告：2030 年趋势、预测与竞争分析

Remdesivir Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

瑞德西韦趋势与预测

预计 2024 年至 2030 年，全球瑞德西韦市场将以 7.0% 的复合年增长率成长。该市场的主要驱动因素是病毒感染病例数量的增加、农村地区不卫生习惯的增加以及对病毒感染预防的需求不断增加。全球瑞德西韦市场未来性广阔，医院药局、零售药局和线上药局市场充满机会。

瑞德西韦市场洞察

Lucintel预测，由于100MG能够抑制SARS-COV-2病毒的复製，因此在预测期内仍将是最大的细分市场。

由于仅凭处方笺配药，医院药房将继续成为该市场最大的部分。

由于 COVID-19 的高流行，预计北美在预测期内仍将是最大的地区。

常问问题

Q1.市场成长预测如何？

A1. 2024年至2030年，全球瑞德西韦市场预计复合年增长率为7.0%。

Q2.影响市场成长的主要驱动因素有哪些？

A2. 该市场的主要驱动因素是病毒感染病例数量的增加、农村地区不卫生习惯的增加以及对病毒感染预防的需求不断增长。

Q3.市场的主要细分市场有哪些？

A3. 瑞德西韦市场未来性广阔，医院药局、零售药局、网路药局市场都有机会。

Q4.市场上主要企业有哪些？

A4.瑞德西韦涉及的主要企业如下。

  • Jubilant Life Sciences
  • Eva Pharma
  • Pfizer
  • Dr. Reddy'S Laboratories
  • Viatris Pharmaceuticals
  • Sun Pharmaceuticals Industries
  • Gilead Sciences India Private

Q5.未来最大的细分市场是什么？

A5.Lucintel 预计 100MG 在预测期内仍将是最大的细分市场，因为它抑制 SARS-COV-2 病毒的复製。

Q6. 未来五年预计哪个地区将成为最大的市场？

A6. 由于 COVID-19 的高流行，北美在预测期内仍将是最大的地区。

Q7. 可以客製化报告吗？

A7. 是的，Lucintel 提供 10% 的客製化服务，无需额外费用。

目录

第一章执行摘要

第二章全球瑞德西韦市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球瑞德西韦市场趋势（2018-2023）与预测（2024-2030）
  • 全球瑞德西韦市场剂量
    • 2.5MG
    • 5MG
    • 100MG
    • 200MG
  • 按型态
    • 冻干粉
    • 浓缩液
  • 按用途
    • 伊波拉
    • SARS-COV
    • MERS-COV
  • 按分销管道
    • 医院药房
    • 零售药房
    • 网路药房

第四章 2018-2030年区域市场趋势及预测分析

  • 全球瑞德西韦市场区域分布
  • 瑞德西韦北美市场
  • 欧洲瑞德西韦市场
  • 亚太地区瑞德西韦市场
  • 其他地区瑞德西韦市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
  • 全球瑞德西韦市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球瑞德西韦市场产能
    • 全球瑞德西韦市场的合併、收购与合资企业
    • 认证和许可

第七章主要企业概况

  • Jubilant Life Sciences
  • Eva Pharma
  • Pfizer
  • Dr. Reddy's Laboratories
  • Viatris Pharmaceuticals
  • Sun Pharmaceuticals Industries
  • Gilead Sciences India Private
简介目录

Remdesivir Trends and Forecast

The future of the global remdesivir market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets. The global remdesivir market is expected to grow with a CAGR of 7.0% from 2024 to 2030. The major drivers for this market are growing cases of viral infections and rise in unhygienic practices in rural areas, and rise in the need for prevention of viral infections.

A more than 150-page report is developed to help in your business decisions.

Remdesivir by Segment

The study includes a forecast for the global remdesivir by dosage, form, application, distribution channel , and region.

Remdesivir Market by Dosage [Shipment Analysis by Value from 2018 to 2030]:

  • 2.5MG
  • 5MG
  • 100MG
  • 200MG

Remdesivir Market by Form [Shipment Analysis by Value from 2018 to 2030]:

  • Lyophilized Powder
  • Concentrated Solution

Remdesivir Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Ebola
  • SARS-Cov
  • MERS-Cov

Remdesivir Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Remdesivir Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Remdesivir Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies remdesivir companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the remdesivir companies profiled in this report include-

  • Jubilant Life Sciences
  • Eva Pharma
  • Pfizer
  • Dr. Reddy'S Laboratories
  • Viatris Pharmaceuticals
  • Sun Pharmaceuticals Industries
  • Gilead Sciences India Private

Remdesivir Market Insights

Lucintel forecasts that 100MG will remain the largest segment over the forecast period due to inhibiting the replication of the SARS-cov-2 virus.

Within this market, hospital pharmacy will remain the largest segment due to prescription-only medication.

North America will remain the largest region over the forecast period due to the high prevalence of COVID-19.

Features of the Global Remdesivir Market

Market Size Estimates: Remdesivir market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Remdesivir market size by various segments, such as by dosage, form, application, distribution channel , and region in terms of value ($B).

Regional Analysis: Remdesivir market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different dosage, form, application, distribution channel , and regions for the remdesivir market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the remdesivir market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for remdesivir market?

Answer: The global remdesivir market is expected to grow with a CAGR of 7.0% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the remdesivir market?

Answer: The major drivers for this market are growing cases of viral infections and rise in unhygienic practices in rural areas, and rise in the need for prevention of viral infections.

Q3. What are the major segments for remdesivir market?

Answer: The future of the remdesivir market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets.

Q4. Who are the key remdesivir market companies?

Answer: Some of the key remdesivir companies are as follows.

  • Jubilant Life Sciences
  • Eva Pharma
  • Pfizer
  • Dr. Reddy'S Laboratories
  • Viatris Pharmaceuticals
  • Sun Pharmaceuticals Industries
  • Gilead Sciences India Private

Q5. Which remdesivir market segment will be the largest in future?

Answer: Lucintel forecasts that 100MG will remain the largest segment over the forecast period due to inhibiting the replication of the SARS-cov-2 virus.

Q6. In remdesivir market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to the high prevalence of COVID-19.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the remdesivir market by dosage (2.5MG, 5MG, 100MG, and 200MG), form (lyophilized powder and concentrated solution), application (ebola, SARS-cov, and MERS-cov), distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Remdesivir Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Remdesivir Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Remdesivir Market by Dosage
    • 3.3.1: 2.5MG
    • 3.3.2: 5MG
    • 3.3.3: 100MG
    • 3.3.4: 200MG
  • 3.4: Global Remdesivir Market by Form
    • 3.4.1: Lyophilized Powder
    • 3.4.2: Concentrated Solution
  • 3.5: Global Remdesivir Market by Application
    • 3.5.1: Ebola
    • 3.5.2: SARS-COV
    • 3.5.3: MERS-COV
  • 3.6: Global Remdesivir Market by Distribution Channel
    • 3.6.1: Hospital Pharmacy
    • 3.6.2: Retail Pharmacy
    • 3.6.3: Online Pharmacy

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Remdesivir Market by Region
  • 4.2: North American Remdesivir Market
    • 4.2.2: North American Remdesivir Market by Distribution Channel : Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
  • 4.3: European Remdesivir Market
    • 4.3.1: European Remdesivir Market by Dosage: 2.5MG, 5MG, 100MG, and 200MG
    • 4.3.2: European Remdesivir Market by Distribution Channel : Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
  • 4.4: APAC Remdesivir Market
    • 4.4.1: APAC Remdesivir Market by Dosage: 2.5MG, 5MG, 100MG, and 200MG
    • 4.4.2: APAC Remdesivir Market by Distribution Channel : Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
  • 4.5: ROW Remdesivir Market
    • 4.5.1: ROW Remdesivir Market by Dosage: 2.5MG, 5MG, 100MG, and 200MG
    • 4.5.2: ROW Remdesivir Market by Distribution Channel: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Remdesivir Market by Dosage
    • 6.1.2: Growth Opportunities for the Global Remdesivir Market by Form
    • 6.1.3: Growth Opportunities for the Global Remdesivir Market by Application
    • 6.1.4: Growth Opportunities for the Global Remdesivir Market by Distribution Channel
    • 6.1.5: Growth Opportunities for the Global Remdesivir Market by Region
  • 6.2: Emerging Trends in the Global Remdesivir Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Remdesivir Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Remdesivir Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Jubilant Life Sciences
  • 7.2: Eva Pharma
  • 7.3: Pfizer
  • 7.4: Dr. Reddy's Laboratories
  • 7.5: Viatris Pharmaceuticals
  • 7.6: Sun Pharmaceuticals Industries
  • 7.7: Gilead Sciences India Private